N/A; N/A
Introduction: Patients with diabetes have been classified as having a high or very high cardiovascular risk. The 2021 guidelines from the European Society of Cardiology (ESC) emphasize the ongoing need for improved development of risk scores specifically tailored for evaluating cardiovascular risk in individuals with type 2 diabetes mellitus. Acknowledging this necessity, the ESC guidelines of 2023 introduced S...
n/a.; n/d.
N/a.; N/a.
Introduction: We sought to evaluate if internal medicineoutpatients are candidates to COMPASS trial strategy (lowdose rivaroxaban twice a day plus daily acetylsalicylic acid),to detail the inclusion and exclusion criteria of COMPASS trial presented by internal medicine patients and to evaluate the frequency of patients already under the strategy. Methods: Observational, retrospective, and transversalstudy in an...
N/a.; N/a.
Respiratory disease and atrial fibrillation (AF) frequent coexist, but the risk of AF among asthma patients is less characterized. Growing evidence suggest that AF shares with asthma a systemic inflammation background and asthma treatments, such as beta agonists, have been associated with increased risk of cardiac arrhythmias. The aim of this systematic review was to assess the risk of AF in patients with asthm...